GROUP ONE TRADING, L.P. - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is and the CUSIP is 74366E902. A total of 4 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,659,660
-44.4%
99,500
-8.0%
0.01%
-40.0%
Q2 2023$2,985,722
-11.8%
108,100
-26.6%
0.01%
-16.7%
Q1 2023$3,385,600
+586.6%
147,200
+225.7%
0.01%
+1100.0%
Q4 2022$493,132
-6.1%
45,200
-27.4%
0.00%0.0%
Q3 2022$525,000
-34.1%
62,300
-38.1%
0.00%0.0%
Q2 2022$797,000
-69.3%
100,700
-8.3%
0.00%
-66.7%
Q1 2022$2,600,000
-64.9%
109,800
-49.3%
0.00%
-50.0%
Q4 2021$7,411,000
+4807.9%
216,700
+2449.4%
0.01%
Q3 2021$151,000
+1577.8%
8,500
+4150.0%
0.00%
Q2 2021$9,000
-88.5%
200
-33.3%
0.00%
Q1 2021$78,0003000.00%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 100,700$797,0000.00%
SIMPLEX TRADING, LLC 37,100$293,0000.00%
JANE STREET GROUP, LLC 22,600$179,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders